Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
336.12
-3.63 (-1.07%)
At close: Oct 27, 2025, 4:00 PM EDT
336.12
0.00 (0.00%)
After-hours: Oct 27, 2025, 4:10 PM EDT
Bio-Rad Laboratories Stock Forecast
Stock Price Forecast
The 4 analysts that cover Bio-Rad Laboratories stock have a consensus rating of "Strong Buy" and an average price target of $333.5, which forecasts a -0.78% decrease in the stock price over the next year. The lowest target is $265 and the highest is $409.
Price Target: $333.5 (-0.78%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 1, 2025.
Analyst Ratings
The average analyst rating for Bio-Rad Laboratories stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $387 → $409 | Buy | Maintains | $387 → $409 | +21.68% | Aug 1, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $245 → $265 | Hold | Maintains | $245 → $265 | -21.16% | Aug 1, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $260 → $245 | Hold | Maintains | $260 → $245 | -27.11% | Jun 9, 2025 |
| UBS | UBS | Strong Buy Maintains $355 → $310 | Strong Buy | Maintains | $355 → $310 | -7.77% | May 2, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $400 → $350 | Strong Buy | Maintains | $400 → $350 | +4.13% | May 2, 2025 |
Financial Forecast
Revenue This Year
2.62B
from 2.57B
Increased by 2.05%
Revenue Next Year
2.69B
from 2.62B
Increased by 2.86%
EPS This Year
9.66
from -65.36
EPS Next Year
10.27
from 9.66
Increased by 6.38%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.7B | 2.8B | |||
| Avg | 2.6B | 2.7B | |||
| Low | 2.5B | 2.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.6% | 8.2% | |||
| Avg | 2.0% | 2.9% | |||
| Low | -1.6% | -2.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.88 | 11.76 | |||
| Avg | 9.66 | 10.27 | |||
| Low | 8.14 | 8.10 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 21.8% | |||
| Avg | - | 6.4% | |||
| Low | - | -16.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.